window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Johnson & Johnson

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    SMC approves TALVEY for relapsed multiple myeloma in Scotland

    The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]

    June 9, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Medical devices

    Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

    Viz.ai has entered a collaboration with Johnson & Johnson to [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    SMC accepts guselkumab for Crohn’s disease and ulcerative colitis in NHS Scotland

    The Scottish Medicines Consortium (SMC) has accepted guselkumab for the [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics

    J&J halts Imaavy rheumatoid arthritis trial after no added benefit

    Johnson & Johnson has dropped plans to develop its recently [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends Johnson & Johnson’s TREMFYA for Crohn’s disease and ulcerative colitis in the UK

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CuraCell reports pancreatic cancer findings from personalised TIL therapy programme
    Categories: Advanced Therapies, Clinical & Regulatory, Therapeutic Areas
  • Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
    Categories: Drug Delivery & Formulation, Medical devices, Pharmaceuticals and therapeutics
  • Apoha raises $36M to expand molecular behaviour data platform
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top